Johnson & Johnson (JNJ) EBITDA (2009 - 2026)
Johnson & Johnson (JNJ) recorded EBITDA of $8.3 billion in Q3 2026, down 5.8% from $8.81 billion a year earlier and down 8.8% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Johnson & Johnson's EBITDA came in at $33.29 billion as of Sep 27, 2026, up 7.9% year-over-year; for FY2025, it was $32.87 billion, up 15.9% from FY2024.
- Annual EBITDA has a four-year compound annual growth rate of 5.1% (FY2021 to FY2025).
- Across earlier years, EBITDA came in at $28.35 billion in FY2024 (-2.2%), $29.01 billion in FY2023 (+4.7%), $27.71 billion in FY2022 and $26.9 billion in FY2021.
- Quarterly EBITDA has ranged from $5.5 billion in Q4 2024 to $9.1 billion in Q2 2026 over the past five years.
- On a year-over-year basis, EBITDA rose in six of the last eight quarters, with growth averaging 8.4%.
- Peak year-over-year performance for EBITDA in the last five years was growth of 36.8% in Q4 2025, against a decline of 26.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.1 billion (Q2 2026), $8.37 billion (Q1 2026) and $7.52 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 782.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 8.30 Bn |
| Jun 28, 2026 | 9.10 Bn |
| Mar 29, 2026 | 8.37 Bn |
| Dec 28, 2025 | 7.52 Bn |
| Sep 28, 2025 | 8.81 Bn |
| Jun 29, 2025 | 8.59 Bn |
| Mar 30, 2025 | 7.95 Bn |
| Dec 29, 2024 | 5.50 Bn |
| Sep 29, 2024 | 6.88 Bn |
| Jun 30, 2024 | 8.25 Bn |
| Mar 31, 2024 | 7.72 Bn |
| Dec 31, 2023 | 6.09 Bn |
| Oct 1, 2023 | 7.57 Bn |
| Jul 2, 2023 | 7.75 Bn |
| Apr 2, 2023 | 7.60 Bn |
| Jan 1, 2023 | 8.29 Bn |
| Apr 3, 2022 | 6.12 Bn |
| Oct 3, 2021 | 8.42 Bn |
| Jul 4, 2021 | 8.04 Bn |
| Apr 4, 2021 | 8.49 Bn |
API Access
Johnson & Johnson EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();